Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The CXCR4 promoter is the regulatory DNA sequence located upstream of the C-X-C motif chemokine receptor 4 (CXCR4) gene, which controls the transcription of this critical G protein-coupled receptor (GPCR) [UniProt: P61073]. It contains multiple regulatory elements, including binding sites for transcription factors such as Hypoxia-Inducible Factor 1-alpha (HIF-1α), NF-κB, and Sp1, which are often hijacked in disease states to drive receptor overexpression [Schioppa et al., 2003, Nature Medicine]. In many cancers, the overactivation of the CXCR4 promoter facilitates tumor cell migration, angiogenesis, and metastasis by increasing the density of CXCR4 on the cell surface [Balkwill, 2004, Nature Reviews Cancer]. A notable feature of the CXCR4 promoter is the presence of G-quadruplex (G4) DNA structures, which serve as potential therapeutic targets; small molecules that stabilize these G4 structures can physically impede the transcriptional machinery and downregulate gene expression [Onel et al., 2016, JACS]. While most clinical therapies currently target the CXCR4 receptor protein (e.g., Plerixafor), targeting the promoter offers a strategy to reduce the total receptor pool, which may be beneficial in treating metastatic disease and preventing HIV-1 entry [D'Angelo et al., 2004, JBC]. However, therapeutic challenges include ensuring the specificity of DNA-binding agents to avoid off-target effects on other essential genes and maintaining the normal physiological roles of CXCR4 in hematopoietic stem cell homing [Busillo & Benovic, 2007, Frontiers in Bioscience].
Transcriptional inhibition through G-quadruplex stabilization and competitive inhibition of transcription factor binding sites.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-X-C motif chemokine receptor 4 promoter (CXCR4 promoter) (CXCR4 promoter).